Photosensitzer conjugates for targeting intracellular pathogens
US6610298B2 · kind B2 · utility
6Cited by
5References
79Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 1999 |
| Grant date | Aug 26, 2003 |
| Priority date | — |
| Expiry date | Oct 15, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/863
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The methods of the invention can be used to treat mycobacterial infections, or any disease or disorder that is caused by (or aggravated by) an intracellular pathogen. Accordingly, the invention features methods for treating a subject who has a disorder that is associated with an intracellular pathogen by administering, to a subject, a molecular conjugate that includes a photosensitizer (a term used herein to refer to a light activatable compound) and a targeting moiety, the targeting moiety being capable of targeting the conjugate to the intracellular pathogen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.